311 related articles for article (PubMed ID: 18571160)
21. Identification of the major metabolites of 5-n-butyl-4-{4-[2-(1H-tetrazole-5-yl)-1H-pyrrol-1-yl]phenylmethyl}-2,4-dihydro-2-(2,6-dichloridephenyl)-3H-1,2,4-triazol-3-one, a new angiotensin type 1 receptor antagonist, in rat bile by HPLC-diode array detection-MS and HPLC-MS/MS.
Yan B; Wang G; Sun J; Li X; Zheng Y; Ai H; Lv H; Wu X; Xu J
Biomed Chromatogr; 2007 Sep; 21(9):912-24. PubMed ID: 17428010
[TBL] [Abstract][Full Text] [Related]
22. Atypical Kinetics and Albumin Effect of Glucuronidation of 5-n-Butyl-4-{4-[2-(1H-tetrazole-5- yl)-1H-pyrrol-1-yl]phenylmethyl}-2,4-dihydro-2-(2,6- dichlorophenyl)-3H-1,2,4-triazol-3-one, a Novel Nonpeptide Angiotensin Type 1 Receptor Antagonist, in Liver Microsomes and UDP-Glucuronosyl-transferase.
Peng Y; Zhang X; Zhu Y; Wu H; Gu S; Chang Q; Zhou Y; Wang G; Sun J
Molecules; 2018 Mar; 23(3):. PubMed ID: 29562678
[TBL] [Abstract][Full Text] [Related]
23. Effects of antihypertensive drugs on capillary rarefaction in spontaneously hypertensive rats: intravital microscopy and histologic analysis.
Sabino B; Lessa MA; Nascimento AR; Rodrigues CA; Henriques Md; Garzoni LR; Levy BI; Tibiriçá E
J Cardiovasc Pharmacol; 2008 Apr; 51(4):402-9. PubMed ID: 18427284
[TBL] [Abstract][Full Text] [Related]
24. EXP063, a nonpeptide angiotensin II and beta adrenergic receptor antagonist.
Wong PC; Duncia JV; Chiu AT; Olson RE; Rominger DH; Tam SW; Timmermans PB
J Pharmacol Exp Ther; 1993 Nov; 267(2):641-7. PubMed ID: 7902431
[TBL] [Abstract][Full Text] [Related]
25. Effect of angiotensin receptor blockade in the rabbit aorta: influence of the endothelium.
le Tran Y; Forster C
Can J Physiol Pharmacol; 1996 Dec; 74(12):1277-86. PubMed ID: 9047036
[TBL] [Abstract][Full Text] [Related]
26. Pharmacology of LR-B/081, a new highly potent, selective and orally active, nonpeptide angiotensin II AT1 receptor antagonist.
Cirillo R; Renzetti AR; Cucchi P; Guelfi M; Salimbeni A; Caliari S; Castellucci A; Evangelista S; Subissi A; Giachetti A
Br J Pharmacol; 1995 Mar; 114(6):1117-24. PubMed ID: 7620700
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological profile of YM358, a novel nonpeptide angiotensin AT1 receptor antagonist.
Shibasaki M; Fujimori A; Takanashi M; Kusayama T; Tokioka T; Satoh Y; Okazaki T; Uchida W; Inagaki O; Yanagisawa I
Eur J Pharmacol; 1997 Sep; 335(2-3):167-73. PubMed ID: 9369370
[TBL] [Abstract][Full Text] [Related]
28. Revelation on the potency of α(1) -blockers - parallel blockade of angiotensin II receptor: a new finding.
Yadav MR; Gandhi HP; Naik PP; Giridhar R
Pharm Biol; 2012 Apr; 50(4):439-42. PubMed ID: 22136253
[TBL] [Abstract][Full Text] [Related]
29. Differential effect of losartan in female and male spontaneously hypertensive rats.
de P Rodrigues SF; dos Santos RA; Silva-Antonialli MM; Scavone C; Nigro D; Carvalho MH; de Cássia Tostes R; Fortes ZB
Life Sci; 2006 Apr; 78(19):2280-5. PubMed ID: 16337658
[TBL] [Abstract][Full Text] [Related]
30. Blockade of brain angiotensin II type 1 receptor inhibits the development of atrial fibrillation in hypertensive rats.
Nagayama T; Hirooka Y; Kishi T; Mukai Y; Inoue S; Takase S; Takemoto M; Chishaki A; Sunagawa K
Am J Hypertens; 2015 Apr; 28(4):444-51. PubMed ID: 25352232
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277.
Wienen W; Hauel N; Van Meel JC; Narr B; Ries U; Entzeroth M
Br J Pharmacol; 1993 Sep; 110(1):245-52. PubMed ID: 8220885
[TBL] [Abstract][Full Text] [Related]
32. The inhibitory effect of leptin on angiotensin II-induced vasoconstriction is blunted in spontaneously hypertensive rats.
Rodríguez A; Frühbeck G; Gómez-Ambrosi J; Catalán V; Sáinz N; Díez J; Zalba G; Fortuño A
J Hypertens; 2006 Aug; 24(8):1589-97. PubMed ID: 16877962
[TBL] [Abstract][Full Text] [Related]
33. The pharmacologic profile of 606A, a novel angiotensin II receptor antagonist.
Hashimoto Y; Harada Y; Narita H; Naito K; Murata S
J Cardiovasc Pharmacol; 1997 Feb; 29(2):284-90. PubMed ID: 9057080
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological properties of KT3-671, a novel nonpeptide angiotensin II receptor antagonist.
Mochizuki S; Sato T; Furuta K; Hase K; Ohkura Y; Fukai C; Kosakai K; Wakabayashi S; Tomiyama A
J Cardiovasc Pharmacol; 1995 Jan; 25(1):22-9. PubMed ID: 7723348
[TBL] [Abstract][Full Text] [Related]
35. A proteomic analysis of aorta from spontaneously hypertensive rat: RhoGDI alpha upregulation by angiotensin II via AT(1) receptor.
Bian YL; Qi YX; Yan ZQ; Long DK; Shen BR; Jiang ZL
Eur J Cell Biol; 2008 Feb; 87(2):101-10. PubMed ID: 17963997
[TBL] [Abstract][Full Text] [Related]
36. Regional hemodynamic effects of neutral endopeptidase inhibition and angiotensin (AT(1)) receptor antagonism alone or in combination in conscious spontaneously hypertensive rats.
Gardiner SM; March JE; Kemp PA; Ballard SA; Bennett T
J Pharmacol Exp Ther; 2006 Oct; 319(1):340-8. PubMed ID: 16825530
[TBL] [Abstract][Full Text] [Related]
37. Peroxisome proliferator-activated receptor alpha activation attenuated angiotensin type 1-mediated but enhanced angiotensin type 2-mediated hemodynamic effects to angiotensin II in the rat.
Banks T; Oyekan A
J Hypertens; 2008 Mar; 26(3):468-77. PubMed ID: 18300857
[TBL] [Abstract][Full Text] [Related]
38. A novel Sartan derivative with very low angiotensin II type 1 receptor affinity protects the kidney in type 2 diabetic rats.
Izuhara Y; Sada T; Yanagisawa H; Koike H; Ohtomo S; Dan T; Ito S; Nangaku M; van Ypersele de Strihou C; Miyata T
Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1767-73. PubMed ID: 18658044
[TBL] [Abstract][Full Text] [Related]
39. Effect of the AT₁ receptor antagonist losartan on diurnal variation in pain threshold in spontaneously hypertensive rats.
Pechlivanova DM; Markova PP; Stoynev AG
Methods Find Exp Clin Pharmacol; 2010 Nov; 32(9):663-8. PubMed ID: 21225017
[TBL] [Abstract][Full Text] [Related]
40. Regulatory effect of hydrogen sulfide on vascular collagen content in spontaneously hypertensive rats.
Zhao X; Zhang LK; Zhang CY; Zeng XJ; Yan H; Jin HF; Tang CS; DU JB
Hypertens Res; 2008 Aug; 31(8):1619-30. PubMed ID: 18971538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
